Replimune Group, Inc. — Director's Dealing 2020

Aug 18, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2020-08-17

Reporting Person: Love Colin (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-17	Common Stock	S	9036	$23.60	Disposed	1042488	Direct
2020-08-17	Common Stock	S	5964	$23.19	Disposed	1036524	Direct

Footnotes

F1: The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.

F2: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.29 to $24.28.

F3: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.07 to $23.27.

F4: Following the sales reported on this Form 4, the reporting person continues to beneficially own 1,036,524 shares of the Issuer's common stock. The reporting person also holds options to acquire 444,653 shares of the Issuer's common stock, 188,185 of which are exercisable as of the date hereof.